Home
/ IN8Bio
/ Competitors

IN8Bio Competitors and Similar CompaniesClear all

IN8Bio's competitors and similar companies include FORMA Therapeutics, Revolution Medicines and OBI Pharma.

	IN8Bio IN8Bio (formerly known as Innatus Therapeutics, Incysus Therapeutics) is a clinical-stage biopharmaceutical company focused on the development of gamma-delta T cell therapies for the treatment of cancer.	FORMA Therapeutics FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines.	Revolution Medicines Revolution Medicines (RevMed) is a clinical-stage oncology company that develops therapies for cancer patients.	OBI Pharma OBI Pharma (台灣浩鼎) is a bio-pharma company focused on cancer therapeutics.
Founding Date	Founding Date 2016	Founding Date 2008	Founding Date 2014	Founding Date 2002
Type	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations New York, US HQ Birmingham, US	Locations Watertown, US HQ	Locations Redwood City, US HQ Redwood City, US	Locations TW HQ San Diego, US
Employees	Employees 13	Employees 77	Employees 37854% increase	Employees 124
Valuation ($)	Valuation ($) 19.9 m	Valuation ($) 998.7 m	Valuation ($) 8.4 b	Valuation ($) N/A
Financial
Net income	Net income ($19.4m) (FY, 2025)	Net income ($173m) (FY, 2021)	Net income ($1.1b) (FY, 2025)	Net income (NT$2.5b) (FY, 2024)
Funding
Total funding raised	Total funding raised $ 35m	Total funding raised $ 142.5m	Total funding raised $ 226m	Total funding raised N/A